 ?您的位置：對照品 > 對照品 > 對照藥材 > |
|
|
|
| 產(chǎn)品基本信息 |
|
| 產(chǎn)品編號：W750000 |
| 產(chǎn)品名稱：WX 671 |
| 產(chǎn)品CAS：590368-25-5 |
| 規(guī)格含量：5mg |
| 產(chǎn)品價格：面議 |
| 聯(lián)系我們: |
 |
|
 |
|
|
| 產(chǎn)品詳細介紹 |
| 標(biāo)準(zhǔn)品編號: |
W750000 |
| 名稱: |
WX 671 |
| 別名: |
4-[(2S)-3-[3-[(Hydroxyamino)iminomethyl]phenyl]-1-oxo-2-[[[2,4,6-tris(1-methylethyl)phenyl]sulfonyl]amino]propyl]-1-piperazinecarboxylic Acid Ethyl Ester; Upamostat |
| CAS號: |
590368-25-5 |
| 分子式: |
C??H??N?O?S |
| 分子量: |
629.81 |
| 類別: |
Standards; Pharmaceutical/API Drug Impurities/Metabolites; |
| 應(yīng)用: |
WX 671 is the oral pro-drug of the active metabolite WX-UK1, a uPA inhibitor. |
| 參考文獻 |
|
|
|
|
|
|
